Vancomycin Hydrochloride

盐酸万古霉素

Report date: 2026/05/28 20:00:21
NMEQIDP

Base Information

Drug NameVancomycin Hydrochloride
Drug Alias Name去甲基盐酸万古霉素vancomicina万古霉素盐酸盐vancomycinevancomycinum +[21] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitorsPeptidoglycan inhibitors
TargetsPeptidoglycan
Therapy Area/IndicationsEnterococcus faecium infectionsInfective EndocarditisLower Respiratory Tract Infections +[44] 
Global Approved IndicationsEnterocolitisStaphylococcal InfectionsClostridium Infections +[4] 
Approved Indications in ChinaStaphylococcal Infections
Original Approved Country/TerritoryN/A
Original Approved Date1954/01/01
Country/TerritoryCanadaUnited StatesNetherlands +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesXellia PharmaceuticalsZhejiang Novus Pharmaceuticals Co LtdHikma +[23] 
Inactive CompaniesSavara IncCase Western Reserve UniversityDrexel University +[23] 
Active IndicationsEnterococcus faecium infectionsInfective EndocarditisLower Respiratory Tract Infections +[29] 
Inactive IndicationsObesityRenal InsufficiencyGraves Ophthalmopathy +[15] 

Other Information

ATC CodeA07AA09J01XA01S01AA28
Related LinksWikipediaDrugBankKEGG